In vitro andin vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)-Reference-Cited by-同舟云学术

In vitro andin vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)

Published:2002-11-13 Issue:5 Volume:102 Page:463-468
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

McClue Steven J.,Blake David,Clarke Rosemary,Cowan Angela,Cummings Lorna,Fischer Peter M.,MacKenzie Mairi,Melville Jean,Stewart Kevin,Wang Shudong,Zhelev Nikolai,Zheleva Daniella,Lane David P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cancer Cell Cycles

2. The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer

3. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

4. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression

Cited by 343 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer;European Journal of Medicinal Chemistry;2024-10

2. Pyrazine-based small molecule kinase inhibitors: clinical applications and patent review (2019–2023);Future Medicinal Chemistry;2024-08-27

3. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis;Phytomedicine;2024-06

4. Centrosomes and associated proteins in pathogenesis and treatment of breast cancer;Frontiers in Oncology;2024-03-28

5. Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review;ChemMedChem;2024-03-26